15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $2.4B | $3.2B | 0.0% | 251.9% | 11.2% | 0.4% | — | — | $22.0B |
| 2024 | $2.2B | $4.2B | 0.0% | 267.1% | 15.4% | 0.6% | — | — | $20.1B |
| 2023 | $2.2B | $1.4B | 0.0% | 256.8% | 4.6% | 0.2% | — | — | $20.6B |
| 2022 | $2.1B | $2.4B | 0.0% | 283.3% | 7.9% | 0.4% | — | — | $20.2B |
| 2021 | $2.1B | $6.4B | 0.0% | 0.0% | 9.4% | 0.8% | — | — | $20.0B |
| 2020 | $1.4B | $5.4B | 0.0% | 0.0% | 7.3% | 0.7% | — | — | $19.8B |
| 2019 | $1.3B | $5.9B | 0.0% | 0.0% | 8.9% | 0.8% | — | — | $16.6B |
| 2018 | $1.3B | $5.1B | 0.0% | 0.0% | 9.7% | 0.7% | — | — | $15.8B |
| 2017 | — | $4.0B | — | — | 6.8% | 0.6% | — | — | $12.7B |
| 2016 | — | $850M | — | — | 1.3% | 0.1% | — | — | $12.7B |
| 2015 | — | $5.4B | — | — | 7.9% | 0.6% | — | — | $11.2B |
| 2014 | — | $6.3B | — | — | 8.7% | 0.7% | — | — | $9.2B |
| 2013 | — | $3.4B | — | — | 5.5% | 0.4% | — | — | $6.5B |
| 2012 | — | $1.3B | — | — | 2.1% | 0.2% | — | — | $15.7B |
| 2011 | — | $6.4B | — | — | 11.2% | 0.8% | — | $24.4B | $10.5B |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $724M | $736M | 0.0% | 221.5% | 2.7% | 0.1% | — | — | $19.3B |
| Mar '26 | $734M | $1.2B | 0.0% | 222.2% | 4.3% | 0.2% | — | — | $22.7B |
| Dec '25 | $600M | $809M | 0.0% | 279.8% | 2.8% | 0.1% | — | — | $22.0B |
| Sep '25 | $621M | $896M | 0.0% | 265.7% | 3.1% | 0.1% | — | — | $20.2B |
| Jun '25 | $604M | $729M | 0.0% | 230.6% | 2.6% | 0.1% | — | — | $22.2B |
| Mar '25 | $611M | $945M | 0.0% | 231.6% | 3.4% | 0.1% | — | — | $21.3B |
| Dec '24 | $556M | $1.3B | 0.0% | 268.2% | 4.6% | 0.2% | — | — | $20.1B |
| Sep '24 | $554M | $1.3B | 0.0% | 260.3% | 4.3% | 0.2% | — | — | $21.8B |
| Jun '24 | $558M | $946M | 0.0% | 297.8% | 3.5% | 0.1% | — | — | $20.8B |
| Mar '24 | $577M | $867M | 0.0% | 242.8% | 3.0% | 0.1% | — | — | $19.8B |
| Dec '23 | $567M | $607M | 0.0% | 0.0% | 2.0% | 0.1% | — | — | $20.6B |
| Sep '23 | $554M | $489M | 0.0% | 0.0% | 1.9% | 0.1% | — | — | $14.9B |
| Jun '23 | $546M | $402M | 0.0% | 0.0% | 1.3% | 0.1% | — | — | $15.4B |
| Mar '23 | $562M | $80M | 0.0% | 0.0% | 0.2% | 0.0% | — | — | $18.5B |
| Dec '22 | $524M | $1.6B | 0.0% | 0.0% | 5.3% | 0.2% | — | — | $20.2B |
| Sep '22 | $511M | $1.2B | 0.0% | 0.0% | 4.6% | 0.2% | — | — | $22.2B |
| Jun '22 | $525M | $910M | 0.0% | 0.0% | 2.5% | 0.1% | — | — | $20.5B |
| Mar '22 | $550M | $1.6B | 0.0% | 0.0% | 3.0% | 0.2% | — | — | $23.5B |
| Dec '21 | $529M | $1.2B | 0.0% | 0.0% | 1.8% | 0.2% | — | — | $20.0B |
| Sep '21 | $516M | $1.6B | 0.0% | 0.0% | 2.3% | 0.2% | — | — | $19.0B |
How the market has priced MET against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, MetLife's revenue has grown 12.5% per year, and net income declined 10.1% per year. These are computed facts, not advice.
As of FY2025, MetLife reported — of total debt against $22.0B of cash; operating income covered interest expense 5.8×.
In FY2025, gross margin was —, operating margin 251.9%, and net margin 130.3%.
As of Sep '26, MetLife traded at a price-to-earnings ratio of about 19.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.